← Open Payments lookup

HANNAH KERMAN: Open Payments

NPI 1184368896 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,605 in 71 payments from 20 companies in 2025. Trend: 2023 $313 · 2024 $1,311 · 2025 $1,605

Food & beverage: $1,605
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$261
Regeneron Healthcare Solutions, Inc.14$227
Novartis Pharmaceuticals Corporation9$191
GENZYME CORPORATION2$146
ANI Pharmaceuticals, Inc.5$140
Amgen Inc.5$98
ARS Pharmaceuticals Operations, Inc.4$98
Organon LLC8$86
Genentech USA, Inc.3$72
Blueprint Medicines Corporation2$53

Products named: DUPIXENT, PURIFIED CORTROPHIN GEL, AIRSUPRA, TEZSPIRE, NEFFY, Xolair, FASENRA, AYVAKIT.

Industry payments across TX — which companies pay providers there.